Arrowhead Pharmaceuticals, Inc. (ARWR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.61B |
| Enterprise Value | 4.75B |
| P/E Ratio | -38.89 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 18.33 |
| Price/Book Ratio | 26.83 |
| Enterprise/Revenue | 19.54 |
| Enterprise/EBITDA | -93.21 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.48 |
| Operating Margin | -0.34 |
| Return On Assets | -0.15 |
| Return On Equity | -0.61 |
| Revenue | 829.45M |
| Revenue/Share | 4.67 |
| Gross Profit | 829.45M |
| EBITDA | 164.82M |
| Net Income | -1.63M |
| Diluted EPS | -0.01 |
| Total Cash | 1.6B |
| Total Cash/Share | 11.17 |
| Total Debt | 864.07M |
| Total Debt/Equity | 1.86 |
| Current Ratio | 5.9 |
| Book Value Per Share | 3.25 |
| 52-Week Change | 308.39 |
| 52-Week High | 95.49 |
| 52-Week Low | 20.45 |
| Moving Average 50 Days | 82.51 |
| Moving Average 200 Days | 68.84 |
| Average Volume | 2.06M |
| Shares Outstanding | 140.86M |
| % Held by Institutions | 84.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.12 |
| Last Split Factor | 1:10 |
| Last Split Date | November 17, 2011 |